NCT04721106 2026-02-10Korea Post Marketing Surveillance (PMS) Study of VizimproPfizerCompleted188 enrolled
NCT04609319 2025-05-31Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart ReviewPfizerCompleted307 enrolled 25 charts